ArticleFrontiers in endocrinology2024

The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner.

James E Blevins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.